Warning: mkdir(): No space left on device in /www/wwwroot/zhenghe1718.com/func.php on line 127

Warning: file_put_contents(./cachefile_yuan/pkscc.com/cache/e4/c2b91/f6020.html): failed to open stream: No such file or directory in /www/wwwroot/zhenghe1718.com/func.php on line 115
THZ1,CovalentCDK7Inhibitor M60214-2s|产品详情|进口橙子视频旧款采购网




  • 橙子视频app安卓下载,91橙子视频,橙子视频旧款,橙子视频在线官网

    订购信息
    上海橙子视频app安卓下载生物科技公司
    Tel:400-968-7988    021-33779008
    THZ1,CovalentCDK7Inhibitor
    品牌:Xcessbio
    货号:M60214-2s
    规格:2 mg solid
    货期:

    THZ1,CovalentCDK7Inhibitor

    商品详情 参考文献 相关资料
    Product Information
    Molecular Weight: 566.05
    Formula: C31H28ClN7O2
    Purity: ≥98%
    CAS#: 1604810-83-4
    Solubility: DMSO up to 50 mM
    Chemical Name: (E)-N-(3-((5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)-4-(4-(dimethylamino)but-2-enamido)benzamide
    Storage: Powder: 4oC 1 year. DMSO: 4oC 3 month; -20oC 1 year.

    Biological Activity:

    THZ1 is a novel potent, selective and cell permeable irreversible CDK7 inhibitor with an IC50 ~3.2 nM. It has the unprecedented ability to target a remote cysteine residue located outside of the canonical kinase domain, providing an unanticipated means of achieving selectivity for CDK7. Cancer cell line profiling indicates that a subset of cancer cell lines, including human T-cell acute lymphoblastic leukaemia (T-ALL), have exceptional sensitivity to THZ1. It strongly reduces the proliferation and cell viability of T-ALL cell lines. Genome-wide analysis in Jurkat T-ALL cells shows that THZ1 disproportionally affects transcription of RUNX1 and suggests that sensitivity to THZ1 may be due to vulnerability conferred by the RUNX1 super-enhancer and the key role of RUNX1 in the core transcriptional regulatory circuitry in these tumor cells. THZ1 exhibited efficacy in a bioluminescent xenografted mouse model using the human T-ALL cell line KOPTK1. Pharmacological modulation of CDK7 kinase activity by using THZ1 may thus provide an approach to identify and treat tumor types that are dependent on transcription for maintenance of the oncogenic state.

     

    How to Use:

    • In vitro:  THZ1 was used at 0.25-2.5 µM final concentration in various in vitro assays.
    • In vivo: THZ1 was dosed to the KOPTK1 T-ALL human xenograft mice via IV injection in the lateral tail vein at 10 mg/kg once or twice per day in a volume of 3.3 μL/g. Formulation is 10% DMSO in D5W. 

     

    Reference:

    1. 1. Kwiatkowski N, et al. Targeting transcription regulation in cancer with a covalent CDK7 inhibitor. (2014) Nature. 511(7511):616-20.

     



    Products are for research use only. Not for human use. 

    • 关于橙子视频app安卓下载
    • 购物流程
    • 支付方式
    • 配送方式
    Copyright@ 2003-2026  进口橙子视频旧款采购网版权所有     

    BIOLEAF热搜   BIOLEAF91橙子视频   BIOLEAF ELISA   BIOLEAF橙子视频旧款   BIOLEAF品牌   BIOLEAF抗体   BIOLEAF耗材   BIOLEAF小仪器

    sitemap   细胞库查询   危险品图标

    本公司网站所展示销售的产品仅供科研!

             沪ICP备08023583号-6     
    产品咨询
    QQ扫码沟通
    在线客服
    服务电话
    400-968-7988
    扫码关注
    微信公众号二维码

    沪公网安备 31011202007338号

    网站地图